LyGenesis Funding & Investors
LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
lygenesis.comTotal Amount Raised: $45,731,260
LyGenesis Funding Rounds
Series A
$19,000,000
Series A Investors
JuvenescencePrime Movers LabSeries Unknown
$8,731,261
Convertible Note
$11,000,000
Convertible Note Investors
JuvenescenceLongevity Vision FundDebt Financing
$4,000,000
Debt Financing Investors
JuvenescenceLongevity Vision FundSeries A
$3,000,000
Series A Investors
Juvenescence
Funding info provided by Diffbot.